close Icon


Burnet Institute is developing biologic and small molecule therapeutics that have potential application in women's health, infectious disease & immunological conditions.

Find us at BIO 2024 this June.

Holding Image
HIV antivirals

In collaboration with Monash Institute of Pharmaceutical Sciences (MIPS), we are developing next-gen...

Holding Image
Therapeutic combating women’s health conditions

A small molecule therapeutic to potentially combat a variety of conditions affecting women’s sexual ...

Holding Image
Enhanced ACE2-Fc protein to treat SARS-CoV-2

A potentially broad spectrum Fc-fusion protein to treat SARS-CoV-2, comprising ACE2 (SARS-CoV-2 rece...